Vivimed gets CCI nod to products sale deal with Clariant

By: |
December 24, 2015 5:09 PM

Other permits and approvals required for the deal are awaited and expected shortly Drug firm Vivimed Labs said the Competition Commission has given its approval to a deal with Clariant Chemicals India to sell some products in its speciality chemicals division. “The Competition Commission of India vide its letter dated December 21, 2015, has granted […]

Other permits and approvals required for the deal are awaited and expected shortly

Drug firm Vivimed Labs said the Competition Commission has given its approval to a deal with Clariant Chemicals India to sell some products in its speciality chemicals division.

“The Competition Commission of India vide its letter dated December 21, 2015, has granted its approval, under Section 31(1) of the Competition Act, 2002, with respect to the proposed acquisition of certain products in Speciality Chemicals division of the company by Clariant India,” Vivimed Labs said in a BSE filing.

The order of the CCI will be received in due course of time, the company said, adding that other permits and approvals required for the deal are awaited and expected shortly.

In September, Vivimed had signed a pact for sale of some of products in its speciality chemicals division to Clariant Chemicals India at an enterprise value of Rs 380 crore.

The company has signed a definitive agreement for the transfer and sale of identified products within speciality division to Clariant’s subsidiary Clariant Chemicals India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.